abstract |
The present invention provides a monoclonal antibody against ILT2, or an antigen-binding portion thereof, as well as a pharmaceutical composition comprising the same, and a method for preparing the same. Also provided is a method of treating cancer comprising administering an antibody or composition of the invention. Methods of treating cancer, combination therapy, and patient selection are also provided. |